Drugs / VGN-Ex05e
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07433517 | Apr 2026 → Oct 2027 expected | autism spectrum disorder | Shanghai Jiao Tong University School of Medicine | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VGN-Ex05e | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07433517 ↗ |
| Route | Other | “intracerebral injection of VGN-Ex05e solution into the nucleus accumbens” NCT07433517 ↗ |